GlassScriptPhysician profile
Erik Paul Shultz
NPI 1811936941
$3,280.06
in general payments reported to CMS, 2019-2025
38 companies · $396 in 2025
The $396 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $98.74 · 2021: $543 · 2022: $365 · 2023: $749 · 2024: $504 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.06 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $377.40 | 2019-2023 | |
| Astellas Pharma US INC | $288.15 | 2022-2025 | Veozah |
| Coopersurgical, INC. | $260.69 | 2019-2024 | Advincula Delineator Uterine Manipulator, Paragard T 380a, Summit Doppler |
| Exeltis, USA INC. | $241.92 | 2019-2024 | Slynd |
| Abbvie INC. | $208.27 | 2019-2022 | |
| Pfizer INC. | $196.00 | 2019-2022 | |
| Sage Therapeutics, LLC | $191.76 | 2024-2025 | Zurzuvae |
| Organon LLC | $151.27 | 2021-2024 | Nexplanon |
| Sumitomo Pharma America, INC. | $150.14 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $139.69 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $107.89 | 2022-2024 | |
| Therapeuticsmd, INC. | $105.48 | 2019-2021 | |
| Medtronic, INC. | $92.23 | 2023-2025 | Truclear |
| Hologic Sales and Service, LLC | $86.17 | 2023-2025 | Novasure, Fluent Fluid Management System, Thinprep 2000 Processor |
| Myriad Women'S Health, INC. | $76.62 | 2023 | Myrisk |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $67.40 | 2019-2021 | |
| Allergan, INC. | $60.53 | 2019-2020 | |
| Avion Pharmaceuticals | $56.81 | 2019-2023 | Balcoltra |
| Ethicon US, LLC | $38.97 | 2024 | Ethicon, Dermabond Prineo, Stratafix |
| Gynesonics, INC. | $33.35 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Minerva Surgical, INC | $32.49 | 2019 | |
| Amgen INC. | $29.77 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $27.24 | 2025 | Exparel |
| Supernus Pharmaceuticals, INC. | $24.26 | 2025 | Qelbree |
| Convatec INC. | $23.11 | 2021 | |
| Integra Lifesciences Corporation | $22.96 | 2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Shield Therapeutics INC | $20.80 | 2023 | Accrufer |
| Aspira Women'S Health INC | $18.92 | 2024 | Ova1 |
| Optumhealth Care Solutions, LLC | $18.59 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Lilly USA, LLC | $17.67 | 2025 | Mounjaro |
| Millicent US INC | $16.90 | 2023 | Intrarosa, Femring |
| Evofem Biosciences, INC. | $16.38 | 2023 | Phexxi |
| Vertical Pharmaceuticals, LLC | $15.83 | 2019 | |
| Exact Sciences Corporation | $15.34 | 2025 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $14.54 | 2019 | |
| Scynexis, INC. | $12.56 | 2022 | |
| Lupin INC. | $11.89 | 2021 | |
| Acessa Health INC. | $10.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Shultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.